New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
11:44 EDTESRXExpress Scripts repeats FY14 adjusted EPS view $4.82-$4.94, consensus $4.87
Repeats FY14 adjusted EBITDA view $6.775B-$6.975B. Sees FY14 adjusted EBITDA per adjusted claim $5.20-$5.30. Sees FY14 EPS growth of 17%-20% excluding UNH. Sees FY14 adjusted claims 1.27B-1.33B. Comments from slides that are being presented at the Bank of America Merrill Lynch Healthcare Conference.
News For ESRX From The Last 14 Days
Check below for free stories on ESRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2014
06:22 EDTESRXHorizon Pharma said Duexis, Vimovo to be placed on CVS, Express exlclusion lists
Subscribe for More Information
July 23, 2014
09:30 EDTESRXExpress Scripts downgraded to Neutral from Buy at Cleveland Research
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use